68Ga-PET has emerged as an important diagnostic tool for precise detection and monitoring
of oncological situations. Availability, cost, and radiosynthesis procedure are determining …

A straightforward labeling using generator produced positron emitting 68Ga, which provides
high quality images, may result in kit type production of PET radiopharmaceuticals and make …

The contribution of 68Ga to the promotion and expansion of clinical research and routine
positron emission tomography (PET) for earlier better diagnostics and individualized …

Abstract Introduction The commercially available 68 Ge/68 Ga generators are generally
used in clinical context in conjunction with automated or semi-automated modules for the …

The worldwide utilization of 68Ga‐radionuclide for the fundamental research and clinical
applications is growing exponentially. A broad range of 68Ga‐based imaging agents has …

The construction of the 68 Ge/68 Ga generator has increased application of
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …

Positron emission tomography (PET) is becoming a dominating method in the field of
molecular imaging. Most commonly used radionuclides are accelerator produced 11 C and …

68Gallium-PET (68Ga-PET) agents have significant clinical promise. The radionuclide can
be produced from a 68Ge/68Ga generator on site and is a convenient alternative to …

Abstract Development of new radiopharmaceuticals and their availability are crucial factors
influencing the expansion of clinical nuclear medicine. The number of new 68 Ga-based …

Over the last couple of decades, gallium-68 (68Ga) has gained a formidable interest for PET
molecular imaging of various conditions, from cancer to infection, through cardiac …